Indian Pharma exports to US may increase in 2017-18, Care Ratings
The Dollar Business Bureau Indian Pharma exports to the US may increase in 2017-18 despite pricing pressure and stiff competition. A report released by Care Ratings said that $50 billion worth of drugs are expected to become 'off-patent' in the current year giving hope to the Indian Pharma export market. "The pharma export volumes from India to US, however, are expected to rise. This will be backed by about $55 billion expected sales gain to generics drugs on account of branded drugs going off patent during 2017-19 which will create an opportunity for CRAMS segment. We expect growth rate for CRAMS (Contract Research and Manufacturing Services) to be higher compared to average growth rate of the industry. These factors are likely to support pharma exports from India," ...
Right time for India to revive trade with Iran, says industry body
The Dollar Business Bureau Removing trade restriction from Iran by the United Nations Security Council has opened up huge opportunity for India to import natural gas from Iran without involving Pakistan, an industry body said. “Lifting of Western sanctions now holds the promise of starting an undersea pipeline project that would bring Iranian gas to Porbandar port in Gujarat bypassing Pakistan, which has been the main sticking point for the other multilateral projects of Turkmenistan-Afghanistan-Pakistan-India (TAPI) and Iran-Pakistan-India (IPI),” said Associated Chamber of Commerce & Industry (ASSOCHAM) in its study on ‘India’s Trade with Iran’. With the IPI still stuck and the TAPI project yet to take off, the South Asia Gas Enterprises Pvt Ltd (SAGE) proposed an undersea pipeline bypassing Pakistan’s ...
